Oklahoma City
DormaTarg, Inc is a biotechnology company researching and developing therapeutic drugs for cancer recurrence prevention.
Edmond
Leviathan proposes a next-generation tool that will make it possible to distinguish and examine h...
Norman
Astellas is an international pharmaceutical company intensely focused on five key therapeutic are...
Oklahoma City
The Lupus Multiplex Registry and Repository is finding the genes that cause lupus (also known as ...
Oklahoma City
COARE Biotechnology is a research driven pharmaceutical company dedicated to developing novel the...
Oklahoma City
Arthrokinex is a comprehensive joint health program that can reduce or eliminate joint pain from ...
Oklahoma City
Hyalose specializes in Hyaluronic Acid production and application. The Emergent Technologies Inc....
Oklahoma City
Cytovance? Biologics adds significant value to biopharmaceutical development programs assisting c...
Oklahoma City
Selexys is a development stage biopharmaceutical company focused on the treatment of inflammatory...
AstraZeneca is a global innovation-driven biopharmaceutical company specializing in the discovery...
Oklahoma City
Tetherex is developing a treatment for inflammatory and thrombotic diseases such as Crohn’s...
Oklahoma City
Jortan Pharmaceuticals Inc.?(JORTAN) was founded around aspartic protease inhibitors as potential...
Oklahoma City
Heparinex is a biotechnology company focused on the development of novel recombinant synthesis of...
Oklahoma City
Pure MHC focuses on HLA related immunology tools for vaccine development and immunotherapy valid...
Oklahoma City
Otologic Pharmaceutics, Inc. is an organization formed specifically to commercialize promising te...
Stillwater
Respiron is developing an antiviral drug, RN-1, to treat any existing and emerging strains of inf...
Oklahoma City
Cassion Biotech has developed a bio-superior drug delivery system, HEPylation ? System, which use...
Sapulpa
Kemmx Corporation is a start-up, biotechnology company pioneering the development and commerciali...
Oklahoma City
IPS Research Company provides phase 1-4 inpatient and outpatient clinical trials. IPS Research sp...
Oklahoma City
Biolytx Pharmaceuticals develops a novel antibiotic peptide for use in treatment of serious hospi...